Karydas Daphne

Mineralys Therapeutics, Inc. · Director

Karydas Daphne is listed in public filings as director. This Karydas Daphne insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Mineralys Therapeutics, Inc. (MLYS), and COMPASS Pathways plc (CMPS). Investors use Karydas Daphne's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Mineralys Therapeutics, Inc.MLYS$75k3k sharesSellJun 17, 2026$25.00$25.13